label: url

en: 循環器疾患とは (Chapter 2 循環器疾患)

ja: 循環器疾患とは (Chapter 2 循環器疾患)

en: Ishiyaku Publishers,Inc.

ja: 医歯薬出版 株式会社


en: 不整脈 (Chapter 2 循環器疾患)

ja: 不整脈 (Chapter 2 循環器疾患)


en: 循環器領域における新たな検査法の導入

ja: 循環器領域における新たな検査法の導入

en: Nankodo

ja: 南江堂


en: Ectopic fat deposition, type 2 diabetes mellitus and cardiovascular diseases

ja: 異所性脂肪と2型糖尿病・心臓血管病 【特集 生活の質(QOL:Quality of life)を高める医療最前線ー難治な病気に光明が見えた!ー】

en: Tokushima Medical Association

ja: 徳島医学会

en: There is evidence supporting the notion that excess abdominal fat is predictive of insulin resistance and the presence of related metabolic abnormalities currently referred to as the metabolic syndrome (MetS). Despite the fact that abdominal obesity is a highly prevalent feature of MetS, the mechanisms by which abdominal obesity is causally related to MetS are not fully elucidated. Besides visceral fat accumulation, ectopic lipid deposition, especially in the liver and skeletal muscle, has been implicated in the pathophysiology of diabetes, insulin resistance and obesity-related disorders. In addition, ectopic fat deposition play a critical role in the heart components such as (1) circulatory and locally recruited fat, (2) intra-and extra-myocellular fat, (3) perivascular fat, and (4) pericardial fat. In this review, the contribution of ectopic lipid deposition to global cardiometabolic risk is discussed via possible mechanisms including adipocytokine, insulin resistance and lipotoxicity.


en: 第2章 7. むずかしくてイヤになる動脈硬化のサイエンス

ja: 第2章 7. むずかしくてイヤになる動脈硬化のサイエンス

en: YODOSHA CO., LTD.

ja: 株式会社 羊土社


en: 循環器症候群(第2版)Ⅰ --- Ⅲ.不整脈(多形性心室頻拍)

ja: 循環器症候群(第2版)Ⅰ --- Ⅲ.不整脈(多形性心室頻拍)

en: NIPPONRINSHOSHA Co.,Ltd.

ja: 日本臨牀社


en: 弁膜症疾患診断のポイント

ja: 弁膜症疾患診断のポイント